Original ArticlePyrrolizidine alkaloid-derived DNA adducts are common toxicological biomarkers of pyrrolizidine alkaloid N-oxides
-
Add time:09/24/2019 Source:sciencedirect.com
There are 660 pyrrolizidine alkaloids (PAs) and PA N-oxides present in the plants, with approximately half being possible carcinogens. We previously reported that a set of four PA-derived DNA adducts is formed in the liver of rats administered a series of hepatocarcinogenic PAs and a PA N-oxide. Based on our findings, we hypothesized that this set of DNA adducts is a common biological biomarker of PA-induced liver tumor formation. In this study, we determined that rat liver microsomal metabolism of five hepatocarcinogenic PAs (lasiocarpine, retrorsine, riddelliine, monocrotaline, and heliotrine) and their corresponding PA N-oxides produced the same set of DNA adducts. Among these compounds, lasiocarpine N-oxide, retrorsine N-oxide, monocrotaline N-oxide, and heliotrine N-oxide are for first time shown to be able to produce these DNA adducts. These results further support the role of these DNA adducts as potential common biomarkers of PA-induced liver tumor initiation.
We also recommend Trading Suppliers and Manufacturers of lasiocarpine N-oxide (cas 127-30-0). Pls Click Website Link as below: cas 127-30-0 suppliers
Prev:A 28-day oral toxicity study of echimidine and lasiocarpine in Wistar rats
Next:Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine10/01/2019
- Development of an in vitro screening method of acute cytotoxicity of the pyrrolizidine alkaloid lasiocarpine in human and rodent hepatic cell lines by increasing susceptibility09/27/2019
- An in vitro comparison of the cytotoxic potential of selected dehydropyrrolizidine alkaloids and some N-oxides09/26/2019
- Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat09/25/2019
- A 28-day oral toxicity study of echimidine and lasiocarpine in Wistar rats09/10/2019
- Human CYP3A4-mediated toxification of the pyrrolizidine alkaloid lasiocarpine09/09/2019


